Kotak Alt invests Rs 1445 crore for the acquisition of Viatris' API business by Matrix PharmaKotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient (A...
13 Jun, 2024, 07.19 PM IST
- Matrix Laboratories founder Nimmagadda Prasad doctored government pact for port, industrial projects: CBI
CBI has accused Nimmagadda Prasad of conspiring with public servants to alter the agreement entered into with the government for his port a...
17 May, 2012, 01.12 PM IST
- CBI arrests Matrix Labs founder Nimmagadda Prasad
CBI has accused Prasad of investing money in companies controlled by Jagan as quid pro quo for obtaining thousands of acres of land.
16 May, 2012, 04.20 AM IST
- Mylan Laboratories looks for partners to launch drugs
Matrix Laboratories, which was acquired by Mylan , is exploring new partnerships in India to launch about 100 products.
17 Aug, 2011, 06.02 PM IST
- Bristol-Myers patent plea for HIV drug rejected
India has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...
11 Jan, 2011, 07.01 AM IST
- Fortis in talks to buy stake in Care Hospitals
Fortis Healthcare is in talks to buy a majority stake in Hyderabad-based Care Hospitals, which will help the group build its presence in so...
03 Nov, 2010, 05.35 AM IST
- Court asks Matrix not to sell generic of Roche’s cancer drug
The Madras High Court (HC) has asked Hyderabad-based Matrix Laboratories not to make or sell the generic version of Swiss major Roche’s can...
23 Sep, 2010, 02.18 AM IST
- Matrix Labs pulled up for quality breach
The incidence of failure to meet the quality norms in the pharmaceutical sector has been on the rise. Now, Hyderabad-based Matrix Laborator...
29 Jul, 2009, 01.14 AM IST
- Lupin shares drop by 5 pc on BSE
Shares of pharmaceutical firm Lupin fell by nearly five per cent in early trade on the Bombay Stock Exchange, a day after EU said it has in...
09 Jul, 2009, 01.07 PM IST
- Matrix Labs hits upper circuit on delisting plans
Shares of Matrix Laboratories were in the limelight after its parent Mylan Inc said it plans to acquire the remaining 29 per cent in the In...
27 Mar, 2009, 10.28 AM IST
- Merrill Lynch sells Rs 1.90-cr shares of Matrix Labs
Merrill Lynch Capital Markets ESPANA has sold shares worth Rs 1.90 crore of the pharma company through an open market.
17 Mar, 2009, 04.01 PM IST
- Matrix parent co to invest in Astrix Lab
Matrix Laboratories has assigned its parent company, MP Laboratories, purchase rights to a part of the equity of Astrix Laboratories. Matri...
15 Jan, 2009, 12.19 PM IST
- Matrix Labs receives USFDA approval for Tenofovir tablets
Matrix Laboratories has received tentative approval for its abbreviated new drug application Tenofovir Disoproxil Fumarate tablets of 300 m...
05 Dec, 2007, 09.40 AM IST
- Mylan makes open offer for 20% stake in Matrix
MP Laboratories (Mauritius) Ltd along with US-based generic pharma firm Mylan Laboratories Inc has issued an open offer to the shareholders...
29 Aug, 2006, 06.50 PM IST
- Mylan Labs to acquire 71.5% stake in Matrix
Indian drug maker Matrix Laboratories Ltd on Monday said US-based generic pharma firm Mylan Laboratories Inc will acquire upto 71.5 per cen...
28 Aug, 2006, 11.40 AM IST
- US co Mylan seen closing in on deal with Matrix Labs
US-based generic firm Mylan Laboratories is believed to be close to picking up a controlling stake in Matrix Laboratories.
14 Aug, 2006, 12.41 AM IST
- US' Mylan eyes Matrix
US-based Mylan Laboratories is believed to be in advanced talks with promoters and private equity funds to buy a majority stake in Matrix L...
22 Jun, 2006, 02.02 AM IST